Application of stem cells is also thought to be a reasonable and promising pathway in seeking efficient therapy for Type 1 diabetes (T1D) [16,17,18,19], an immune-auto-aggressive disorder resulting in the destruction of pancreatic insulin-producing β-cells followed by glucose imbalance and its systemic repercussions [20]. Here, INS is linked to type 1 diabetes mellitus.